RxDoctor Payments Data

Eduardo Alvarez Seijas

Family · Miami, FLNPI 1962224857

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.5% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Insulet Corporation at 28.7% of the total.

$2,177in general payments, 2019–2025

Across 107 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insulet Corporation$626
  • Novo Nordisk$298
  • Lilly USA, LLC$141
  • Bayer$137
  • Corcept Therapeutics$135
  • Xeris Pharmaceuticals, Inc.$132
  • plus $707 from 13 others

What the payments were for

  • Food & beverage$2,14499%
  • Education$321%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,177 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Other family in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →